We consider the privacy implications surrounding collection and use of COVID-19 vaccination status information.
The Prescription - December 2021
By Lucille Scomazzon, Aaron Kloczko, Ben Miller, Angela Wood, Steven Tang, Damien Wurzel, Tamie Duncan-Bible, Anthony Willis, Brendan Coady, Stephen Rohl, Shelley Einfeld, Sophie Vo, Jenny Wong, Benjamin Duff, Emma Woelke, Natasha Faigenbaum and Xinyu Zhang.
In this edition
-
Legal Insights
-
Legal Insights
We review the Full Federal Court’s decision in Ariosa v Sequenom regarding the patentability of diagnostic testing methods.
-
Legal Insights
We compare two recent decisions of the Federal Court regarding the relevant goods when applying for a patent term extension.
-
Legal Insights
We consider the Federal Court’s decision in Thaler v Commissioner of Patents that artificial intelligence can be the inventor of a patent.
-
Legal Insights
We provide an update on the mandatory COVID-19 vaccination frameworks in residential aged care.
-
Legal Insights
We outline proposed good governance reforms to the Aged Care Act 1997 and the Aged Care Quality and Safety Act 2018 following the Royal Commission into Aged Care Quality and Safety.
-
Legal Insights
We review the Therapeutic Goods Administration’s new framework for regulating custom-made medical devices.
-
Legal Insights
We provide a summary of the Therapeutic Goods Administration’s permissions for the advertising of therapeutic goods for COVID-19.
-
Legal Insights
We provide an update on personal protective equipment regulation through the COVID-19 pandemic.
-
Legal Insights
We review the Federal Court’s decision to impose the largest ever fine for unlawfully advertising products containing therapeutic substances.
-
Legal Insights
We consider the Full Federal Court’s decision in Allergan v Self Care regarding the deceptive similarity of PROTOX to BOTOX.
-
Legal Insights
We outline the recent reforms to design law in Australia.
-
Legal Insights
We discuss the Australian Government’s new strategic agreement with Medicines Australia.
-
Legal Insights
We discuss the Australian Government’s new strategic agreement with the Generic and Biosimilars Medicines Association.